SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950137-04-006783
Filing Date
2004-08-13
Accepted
2004-08-13 17:14:52
Documents
6
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT c87533e10vq.htm 10-Q 249821
2 WAIVER AND MODIFICATION OF BANK COVENANTS c87533exv10w1.htm EX-10.1 39504
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER c87533exv31w1.htm EX-31.1 4890
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER c87533exv31w2.htm EX-31.2 4896
5 906 CERTIFICATION OF CHIEF EXECUTIVE OFFICER c87533exv32w1.htm EX-32.1 2390
6 906 CERTIFICATION OF CHIEF FINANCIAL OFFICER c87533exv32w2.htm EX-32.2 2395
  Complete submission text file 0000950137-04-006783.txt   306132
Mailing Address 100 TRI STATE INTERNATIONAL SUITE 100 LINCOLNSHIRE IL 60069
Business Address 2500 MILLBROOK DRIVE BUFFALO GROVE IL 60089 8472796100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

IRS No.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-13976 | Film No.: 04975280
SIC: 2834 Pharmaceutical Preparations